Validation in plasma samples from prostate cancer patients and cancer-free individuals underscored the diagnostic and prognostic relevance of two genes, OR51E2 and SIM2, along with two miRNAs, miR-200c and miR-200b, in distinguishing prostate cancer presence with notable sensitivity and specificity [172]. Here, SIM2 is linked to prostate carcinoma.